Study #2023-0941
Evaluation of a Simple-Prep Controlled Embolic (GPX Trial)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The objective of this study is to evaluate the safety and effectiveness of the GPX® Embolic Device when used as indicated for embolization requiring distal vessel penetration in 114 subjects in up to 25 investigational sites in the USA, New Zealand, and Canada.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Embolism;Vascular Tumor;Renal Angiomyolipoma;Renal Cell Carcinoma;Bone Tumor;Portal Vein Embolism
Study phase:
Not applicable
Physician name:
Stephen Chen
Department:
Interventional Radiology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.